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Reverse transfectionPromoters are the best characterized transcriptional regulatory sequences in complex genomes because of
their predictable location immediately upstream of transcription start sites. Despite a substantial body of
literature describing transcriptional promoters, the identiﬁcation of true start sites for all human transcripts
is far from complete. The same is true of the key structural and functional elements responsible for promoter
action in different cell types. In order to identify elements responsible for promoter activity, we applied
transfected-cell array technology to functionally evaluate promoters for genes involved in inﬂammatory
bowel disease. Seventy-four promoters were examined by reverse transfection of a promoter-ﬂuorescent
reporter constructs into a human embryonic kidney cell line (HEK293T). Sixteen (21.6%) promoters were
found to be active in HEK293 T cells. Correlations between promoter activity and endogenous transcript level
were calculated, and 75% of active promoters were found to be associated with transcriptional activity of
their gene counterparts. These results provide experimental evidence of promoter activity, which may aid in
understanding the regulation of gene expression. Moreover, this is the ﬁrst large-scale functional study of
regulatory sequences to use a high-throughput transfected-cell array technique.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Gene expression in eukaryotes is known to be an extraordinarily
complex process involving a variety of steps, including transcription,
RNA processing, mRNA stabilization, translation and protein modiﬁ-
cation. Regulation of transcriptional initiation plays a crucial role in
this cascade, and several DNA sequence elements are known to
contribute to transcriptional initiation. Promoters, located immedi-
ately upstream of transcriptional start sites (TSSs), are likely one of
the most important elements in this regulation.idine; CAGE, cap analysis gene
rochloride; DMEM, Dulbecco’s
g; G, guanosine; HEK, human
000 bp; N, any nucleoside; T,
n start site.
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Immunology, Department of
ll rights reserved.Promoters consist of twoparts, including the core promoter and the
extended promoter regions. The core promoter is a small contiguous
DNA sequence that interacts directly with components of the basal
transcription machinery and initiates transcription. This region is
usually located within 150 bp of the TSS (Sandelin et al., 2007; Müller
et al., 2007). Extended promoter regions, located between hundreds
and thousands of bp away from the TSS, contain other cis-acting DNA
elements, such as the insulator, enhancer and silencer.
The availability of the genome sequences of many eukaryotic
organisms has made global characterization of gene regulation one of
the major fundamental goals of biomedical research. Intensive efforts
have recently been invested in developing sequence-based and
hybridization-based approaches for identifying TSSs and promoters
on a genome-wide scale (Cooper et al., 2006; ENCODE Project
Consortium, 2007). As a result, a large number of novel transcripts
and promoters have been revealed. However, the function of these
promoters in vivo remains unknown without sufﬁcient experimental
data. Functional studies are mainly performed using reporter gene
assays, which require large numbers of transfection experiments and,
thus, limit genome-wide characterization of promoters.
In the presentwork, we describe the application of high-throughput
transfected-cell arrays (Vanhecke and Janitz, 2004) in a functional study
of eukaryotic promoters. Seventy-four promoter fragments for genes
potentially involved in the pathomechanism of inﬂammatory bowel
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by still unknown polygenic factors. However, recent technological
advances have helped to reveal the genetic etiology and transcriptomic
landscape of such complex diseases. Combining murine models with
patient-derived data has substantially contributed to understanding the
early events of etiopathogenesis. Application of this approach has
revealed that a primary deﬁciency of the innate immunological barrier
function exists in the group of diseases that includes inﬂammatory
bowel disease (Rosenstiel and Schreiber, 2008). Here, promoter activity
patterns were correlated with the expression proﬁles of corresponding
genes. Furthermore, a comparative analysis between core regulatory
elements and promoter activity proﬁles in human embryonic kidney
(HEK) cells was performed.
2. Materials and methods
2.1. Promoter prediction and PCR ampliﬁcation with attB primers
TSSswere deﬁned using Ensembl 35. In cases without Ensembl gene
annotation, CAGE tags (FANTOM3) and EST-sequences (GeneNest
database) were used to determine putative TSSs. Putative promoter
regions were deﬁned as the sequences directly upstream of TSSs.
The software PRIDE (http://pride.molgen.mpg.de/pride.html)
(Haas et al., 2003) was used to design primer sets to amplify 2.5 kb
DNA fragments upstream of and ﬂanking the TSS of each putative
promoter. First, touchdown PCR of genomic DNAwas performed using
the protocol described by Ralser et al. (2006). To generate PCR
products suitable for use as substrates in Gateway BP recombination
reactions, 12 bases of attB site sequences were added to the 5′ end of
each primer (attB1 forward: 5′-AAAAAGCAGGCTNN-3′; attB2 reverse:
5′-AGAAAGCTGGGTN-3′). Then, a second PCR was performed to
attach the complete attB sequences to the ends of the PCR products
using adapter primers (attB1 adapter: 5′-GGGGACAAGTTTGTA-
CAAAAAAGCAGGCT-3′; attB2 adapter: 5′-GGGGACCACTTTGTACAA-
GAAAGCTGGGT-3′) (Gateway Technology Instruction Manual,
Invitrogen).
2.2. Vector construction, promoter cloning and plasmid preparation
pZsGreen1-1 (Clontech) is a promoterless vector encoding the
green ﬂuorescent protein ZsGreen1. To enable rapid and highly
efﬁcient cloning of the promoter fragment into the vector, pZsGreen1-
1 was converted to a Gateway-adapted vector using restriction
cloning. To do so, the attP1- and attP2-ﬂanked fragment from
pDONR221 (Invitrogen) was inserted into the multiple cloning site
of the pZsGreen1-1 vector.
To clone the ampliﬁed promoter fragments, puriﬁed attB-PCR
products were mixed with the attP-compatible pZsGreen1-1 vector
and incubatedwith Gateway BP Clonase II EnzymeMix (Invitrogen) for
over 3h at 25 °C. Each reaction volumewas10 μl of the total volume, and
the reaction component amounts were calculated following the
Gateway technology instructionmanual. After incubationwith Protein-
ase K for 10 min at 37 °C, the mixture was transformed into One Shot
TOP10 competent cells (Invitrogen). The resulting colonies were
screened by PCR, and plasmids were isolated from positive clones
using a QIAprep Spin Miniprep Kit (Qiagen). The identity of the inserts
was conﬁrmed by sequencing the 5′ and 3′ ends.
pHcRed1-N1, a CMV promoter-driven vector expressing the far-
red ﬂuorescent protein HcRed1 (Clontech), was modiﬁed and used as
a control for spot localization and transfection efﬁciency. The CMV
promoter, with a total length of 589 bp, contains a 407 bp enhancer
region and a 58 bp minimum promoter region. In order to make the
control plasmid comparable to the putative promoters lacking the
enhancer element, 323 bp of the enhancer region was removed by
restriction digestion, resulting in a 266 bp-long 3′ section of the
original CMV promoter upstream of the HcRed reporter gene.2.3. Sample preparation and microarray spotting
Samples for array spotting were prepared using the lipid–DNA
method (LD-method) described by Ziauddin and Sabatini (2001) with
modiﬁcations (Fiebitz et al., 2008). Brieﬂy, 1.6 μg of putative promoter
plasmids and 400 ng of the reference HcRed reporter plasmid were
mixed, and the volumewas adjusted with TE buffer to 6.5 μl. EC buffer
(10 μl, Effectene Kit, Qiagen) supplemented with 0.2 M sucrose
(Invitrogen) was added to the plasmid mixture, which was incubated
with 1.5 μl Enhancer (Qiagen) and then with 7.0 μl Effectene reagent
(Qiagen) at room temperature for 5 min and 10 min, respectively.
Finally, the samples were mixed with 25 μl of 0.2% (w/v) gelatin and
incubated at room temperature for a minimum of 1 h before spotting.
The ﬁnal sample mixture contained 32 ng/μl of promoter construct
and 7.5 ng/μl of reference plasmid.
Standard 25×75×1.0 mm slides covered with poly-L-lysine
(Sigma) and VECTABOND Reagent (Vector Labs) were used for array
printing. The samples were spotted manually with a 2 μl pipette and
long tips (SAFESEAL tips PREMIUM XL 10 μl, Biozmy) by tapping the
slide with the ﬁlled tip. The samples were spotted following a printed
1.5×1.5 mm grid, such that the distance between adjacent spots was
approximately 1.5 mm. The diameter of each spot was between 0.8
and 1.0 mm, and the estimated volume was 10–15 nl. All samples
were arrayed in triplicate. After spotting, the slides were air-dried for
a minimum of 1 h before transfection. For long-term use, slides were
stored in dark, low-humidity conditions at 4 °C.
2.4. Cell culture and reverse transfection
HEK 293T/17 (ATCC, CRL-11268), a cultured HEK cell line, was
used for reverse transfection. Cells were cultured in high glucose
Dulbecco's modiﬁed Eagle's medium (DMEM) (Gibco Invitrogen)
supplemented with 10% (v/v) fetal calf serum (Biochrom), 2 mM L-
glutamine (Gibco Invitrogen) and 50 μg/ml penicillin/streptomycin
(Gibco, Invitrogen). The cells were incubated at 37 °C in humid
conditions with 6% CO2.
Twenty-four hours before transfection, 107 cells were plated onto
a 60 cm2 cell culture dish in 10ml complete growthmedia. On the day
of transfection, cells were harvested and seeded at 3.5×106 per slide
in 7.5 ml complete media in a Quadriperm chamber (Greiner). The
transfected arrays were incubated at 37 °C with 6% CO2 for 48 h. Two
slides were used in parallel. To stop the transfection, slides were ﬁxed
for 30 min in 3.7% formaldehyde with 4 M sucrose in PBS. After
staining with DAPI (4′,6-diamidino-2′-phenylindole dihydrochloride,
SIGMA) andmountingwith Fluoromount-G (Southern Biotech), slides
were covered with 22×64 mm cover glasses and scanned with a
microscope.
2.5. Image acquisition and analysis
All images were acquired using an automated ﬂuorescence
microscope (IX81, Olympus) with custom image acquisition software
Scan^R (Olympus). The microscope was equipped with a high-
resolution CCD camera, and a 10×/1.6 (NA) objective was used. For
each spotting position, single frame images were acquired using DAPI
staining for auto-focusing and red and green channels for ﬂuorescence
signal detection. Background reductionwas achieved using the rolling
circle option for image processing.
Numerical output from the image sets was generated by the
Scan^R Analysis software, an integrated image analysis and data
visualization tool (Olympus). Scan^R Analysis identiﬁed each trans-
fected cell by locating the borders of ﬂuorescent objects in the images
based on the object-ﬁnding algorithm. The watershed option was
used for improved object separation. Cells were considered co-
transfected with both reporters when the ﬂuorescence intensity
50 X. Cheng et al. / Gene 450 (2010) 48–54signals from the ZsGreen1 and HcRed1 reporter constructs exceeded
the set thresholds in the green and red channels, respectively.
In order to identify the promoter activity at each spotting position,
two selection criteria were taken into account, including the number
of co-transfected cells (Nco-tr) and the ratio (Ri) between the number
of co-transfected cells and the total number of red cells (Nred)
(Ri=Nco-tr/Nred). The threshold for the number of co-transfected
cells was deﬁned as three standard deviations above the mean
number of ZsGreen1-positive cells transfected with negative controls
(pZsGreen1-1 vector modiﬁed with pDONR sites) spotted in 10
replicates. The Ri parameter served as a transfection efﬁciency index
andwas empirically set to 0.1. This value provided the best correlation
of promoter activity with the corresponding gene expression level, as
determined by transcriptome sequencing. If the Ri parameter was
greater than 0.1 in at least four out of six replicates, the promoter was
classiﬁed as active. A binary promoter activity index, with 0 indicating
inactive and 1 indicating active, was generated for each investigated
promoter region.2.6. Gene expression proﬁling using the RNA-Seq technique
Publicly available data on gene expression levels in HEK293T cells
are provided at http://promotion.molgen.mpg.de/cgi-bin/gbrowse/
Hs.Solexa. The detailed procedure used for RNA-Seq transcriptome
proﬁling using Illumina Genome Analyzer has previously been
described (Sultan et al., 2008).2.7. Comparison of promoter activities with UniGene expression proﬁles
The T-STAG database of tissue-speciﬁc gene expression was used
to compare tissue-speciﬁc promoter activities. This database, which is
based on UniGene, associates each gene with a set of p-values
describing the likelihood of the gene being expressed in the respective
tissue (Gupta et al., 2005). UniGene clusters of the genes for the
cloned promoters were identiﬁed, and the tissue-speciﬁc expressed
sequence tag (EST) proﬁle was obtained. For each gene, the number of
tissues where ESTs were expressed was determined and compared
with the fraction of active and silent fragments.2.8. Computational sequence analysis of promoter regions
The predicted promoter sequences were analyzed, and common
promoter elements (TATA box and CpG islands) were detected. The
TransFac MATCH tool (Kel et al., 2003) was used to detect TATA box
regions using the position weight matrix TATA_01 (Bucher, 1990).
The sequences of cloned fragments were compared to the map of CpG
islands predicted by Bock et al. (2007), and the recommended
combined epigenetic score (greater than 0.5) was used.3. Results
3.1. Cloning of 74 promoters for selected genes
Potential TSSs were identiﬁed, and the 2.5-kb sequence upstream
of each predicted TSS was selected as the promoter fragment.
Seventy-four putative promoters (listed in Supplementary Table 1)
were successfully ampliﬁed from human genomic DNA using the
previously described PCR protocol designed for ampliﬁcation of GC-
rich promoter regions (Ralser et al., 2006). The putative promoter
regions were cloned into the attP-adapted pZsGreen1-1 vector
upstream of the ﬂuorescent reporter gene ZsGreen1. The insertions
were veriﬁed by sequencing from both the 5′ and 3′ ends.3.2. Identiﬁcation of 16 functional promoters in HEK293T cells
Using transfected-cell technology, cloned promoter fragments
were evaluated for activity in HEK cells, with reporter gene expression
used as the measure of activity (Fig. 1). A cell-based quantiﬁcation
approach was used to determine promoter activity. For each scanning
position, the number of cells transfected with the test promoter
constructs (showing green ﬂuorescence), the control plasmid
HcRed1-1 (showing red ﬂuorescence) or co-transfected (simulta-
neously showing green and red ﬂuorescence) was determined.
Promoter activity was assessed based on two thresholds, including
the minimal number of co-transfected cells and the minimal
transfection ratio index. A promoter fragment was considered active
if it exceeded the combined threshold for at least four replicates out of
six. Using this approach, 16 (21.6%) functional promoters in HEK293T
cells were identiﬁed for the genes listed in Table 1.
The transfection efﬁciency for each spot on the array was
calculated as the ratio of the number of transfected cells to the total
number of cells in the spot area (Fig. 2). The number of transfected
cells was calculated as the sum of cells positive for either green or red
ﬂuorescence; cells that expressed both ﬂuorophores were counted
only once. The average number of transfected cells was approximately
100 cells per spot. The total number of cells per scan position
estimated by DAPI staining was approximately 1000. According to the
area ratio, the number of cells that could theoretically be transfected
was estimated to be approximately 580. Thus, the transfection
efﬁciency was approximately 17.2%, and this value is in agreement
with a previous work utilizing liposome-based reverse transfection, in
which the efﬁciency was slightly over 17% (Baghdoyan et al., 2004).
3.3. Endogenous transcript levels correlated with promoter activity
The activity of cloned promoter fragments was compared with
endogenous transcript levels in the same cell line to identify the
correlation between activity and expression level. This analysis sought
to determine how the ability of a promoter to initiate gene
transcription is inﬂuenced by distal cis-regulatory elements and
post-transcription regulatory mechanisms because neither of these
elements could be monitored in the cell array-based functional assay.
Comparison of promoter activity with the levels of corresponding
mRNA provides the ratio of false positive and negatives.
Endogenous transcript levels were determined previously by
performing high-throughput sequencing of the HEK293T transcrip-
tome using Illumina Genome Analyzer (Sultan et al., 2008). Thus,
expression levels of the genes corresponding to cloned promoters
have been reported. Among the 16 active promoter fragments, 12
(75.0%) of the corresponding genes were expressed. In contrast, of the
58 silent promoter fragments, only 17 (29.3%) of the corresponding
genes were expressed (Fig. 3, Table 1 and Supplementary Table 1).
3.4. Active promoters are enriched for genes with ubiquitous expression
HEK293T were used for reverse transfection experiments, so
promoters for genes with more tissue-speciﬁc activity might not be
functional in this cell line. In contrast, genes with more ubiquitous
expression would be more likely to be expressed in the HEK cell line.
Therefore, the association between transfected promoter activity and
the tissue expression proﬁles of the corresponding genes was
evaluated. For this purpose, UniGene EST clusters of genes
corresponding to the studied promoter fragments were retrieved, and
the number of tissues containing each EST was counted. Subsequently,
the tissue distribution of the ESTs was analyzed in relation to the
promoter activity of the corresponding gene. Using this approach,
tissue expression data was obtained for 67 genes, including 16 active
fragments and 51 silent fragments. A strong correlation was found
between the promoter activity state in HEK293T cells and the number
51X. Cheng et al. / Gene 450 (2010) 48–54of tissues with corresponding ESTs. In 68.8% of active promoters, the
corresponding genes were expressed in more than 25 out of 45
tissues. In contrast, only 12.1% of the inactive promoters corresponded
to genes with a broad expression proﬁle. Furthermore, 50.0% of the
inactive promoters were expressed in less than 10 tissues (Fig. 4).
3.5. Correlation of activity pattern with promoter sequence
characteristics
Core promoters vary in their sequence structure; however, several
key DNA sequence elements can be distinguished. These motifs are
necessary for the binding of general transcription factors and RNA
polymerase II in the pre-initiation complex (Sandelin et al., 2007;
Müller et al., 2007). CpG islands and TATA boxes are of particular
interest due to the epigenetic effects of the former and the necessity ofFig. 1. Workﬂow for promoter analysis using a transfected-cell array. (1) Promoter region
ampliﬁed by PCR. (2) Ampliﬁed promoters were cloned into a reporter plasmid encoding a gr
with a normalization plasmid encoding a red ﬂuorescent protein. Subsequently, the slides w
ﬂuorescence microscopy. (5) Data were analyzed by counting the number of transfected cethe latter for initiation of the transcription process (Gross and
Oelgeschläger, 2006). Therefore, the present promoter set was
analyzed for correlations between the presence of these two sequence
motifs and promoter activity status.
CpG islands are genomic regions with high GC content and a high
frequency of CpG dinucleotides relative to the bulk DNA (Gardiner-
Garden and Frommer, 1987). They are associated with the promoters
of most housekeeping genes as well as many tissue-speciﬁc genes and
play a critical role in gene regulation. Aberrant methylation of
promoter-related CpG islands is a commonmechanism of inactivation
of tumor suppressor genes and is associated with epigenetic causes of
all types of cancer (Herman and Baylin, 2003). Various approaches
have been described and developed for computational prediction and
identiﬁcation of CpG islands (Takai and Jones, 2002; Wang and Leung,
2004; Hackenberg et al., 2006). Most of these approaches are baseds were selected upstream of transcription start sites from the Ensembl database and
een ﬂuorescent protein. (3) Reporter constructs were spotted onto glass slides together
ere covered with HEK293T cells for reverse transfection. (4) Images were acquired by
lls using an object-ﬁnding algorithm.
Table 1
List of genes of which promoters revealed activity in the transfected-cell array.










3 Baculoviral IAP repeat-containing 2 BIRC2 329 +
4 Baculoviral IAP repeat-containing 3 BIRC3 330 +
5 Baculoviral IAP repeat-containing 5
(survivin)
BIRC5 332 +
6 Caspase recruitment domain
family, member 8
CARD8 22900 +
7 CASP2 and RIPK1 domain containing
adaptor with death domain
CRADD 8738 +
8 Dystrobrevin binding protein 1 DTNBP1 84062 +
9 Interferon induced with helicase
C domain 1
IFIH1 64135 −
10 NACHT, leucine rich repeat and PYD
containing 2
NALP2 55655 −









14 Toll-like receptor 1 TLR1 7096 −
15 Toll-like receptor 5 TLR5 7100 +
16 TNFRSF1A-associated via death domain TRADD 8717 +
52 X. Cheng et al. / Gene 450 (2010) 48–54only on sequence criteria. Here, a high-quality map of so-called bona
ﬁde CpG islands in the human genome was used to characterize the
CpG islands in the promoter fragments. This mapwas generated using
a CpG island strength prediction method that links the DNA sequence
of CpG islands to their epigenetic states, including DNA methylation,
histone modiﬁcation and chromatin accessibility (Bock et al., 2007).
CpG islands were detected in 14 (18.9%) out of 74 cloned promoters,
including 7 (43.8%) of the 16 active promoters and 7 (12.1%) of the 58Fig. 2. Cell number counting and transfection efﬁciency calculation. The transfection efﬁcienc
to the total number of cells in the spot area. (a) The total number of cells per scan posit
transfected (within the spot) was estimated according to the area ratio. The numbers of
automatically counted. The number of transfected cells was calculated as the sum of cells po
counted only once.silent promoters (Fig. 5). A 3.6-fold enrichment of CpG islands in active
versus silent fragments was observed. These data agree with the
description by Cooper et al. (2006), stating that the presence of CpG
islands is an important but incomplete indicator of promoter activity.
The TATA box, the best known core promoter element, is located
approximately 30 bp upstream of the TSS. The TATA binding protein
(TBP) binds to this motif and begins assembly of the pre-initiation
complex. TATA boxes are often associated with tissue-speciﬁc
promoters and are correlated with a clearly deﬁned TSS (Schug et
al., 2005; Sandelin et al., 2007). TATA boxes were found in 26 (35.1%)
out of 74 cloned promoters. This fraction is higher than the value
previously reported by Juven-Gershon et al. (2008), who reported
that less than one-third of vertebrate core promoters contained a
TATA box. In the present work, 37.5% of the active fragments and
34.5% of silent fragments contained a TATA box (Fig. 5).
4. Discussion
In this study, transfected-cell array (TCA) technology is presented
as an efﬁcient and cost-effective tool for functional analysis of
predicted promoter regions. Putative promoter regions were located
directly upstream of TSSs predicted by Ensembl gene annotations. For
functional characterization, a 2.5-kb promoter fragment was selected
to include the nearest TSS of the gene. In a previous study by Cooper et
al. (2006), the 300-bp sequence upstream of the TSS contributed
positively to core promoter activity, while sequences 500 to 1000 bp
upstream of the TSS were identiﬁed as negative elements in half of the
cases. Therefore, the 2.5-kb fragments analyzed here likely contained
the full core promoter element as well as more upstream regulatory
sequences.
The cloned fragments were tested for promoter activity in the
HEK293T cell line using the TCA technique. This method allows
parallel analysis of multiple genes and gene products. Furthermore,
this method has been used to screen phenotypes via gene silencing
(Vanhecke and Janitz, 2005), detect protein intracellular localizationy for each spot on the array was calculated as the ratio of the number of transfected cells
ion was counted by ﬂuorescent DAPI. The number of cells that could theoretically be
cells expressing red (b), green (c), or dual ﬂuorescence (d), shown in yellow, were
sitive for either green or red ﬂuorescence; cells that expressed both ﬂuorophores were
Fig. 3. Correlation of promoter activity with endogenous gene expression in HEK293T cells. The Venn diagrams show the degree of agreement between the promoter reporter
activities of 74 tested fragments (indicated as TCA) and the expression data for their associated genes, which was obtained from high-throughput transcriptome sequencing
(indicated as Solexa). (a) Active promoter fragments had a 75.0% overlap with corresponding gene expression. (b) Genes associated with silent promoter fragments were less likely
to be expressed (29.3%).
53X. Cheng et al. / Gene 450 (2010) 48–54(Hu et al., 2006) and investigate protein–protein interactions (Fiebitz
et al., 2008). The present study demonstrates another application of
the TCA technique, namely, a large-scale functional analysis of
transcriptional regulatory elements in living cells.
Overall, 21.6% of the predicted promoters showed activity in the
HEK293T cell line with the transient reverse transfection assay. This
fraction is lower than but comparable to the 30.8% promoter activity
observed in a set of chromosome 21 promoters (unpublished data).
In order to assess the promoter contribution to gene expression in
living cells, the promoter activities were compared to endogenous
mRNA levels of the corresponding genes in HEK293T cells. Of the
promoters that were active in the TCA assay, 75% of the corresponding
genes were expressed. No corresponding transcripts were detected
for 4 promoters, including IFIH1, NALP2, NALP4 and TLR1. IFIH1, also
known as the melanoma differentiation-associated 5 (MDA-5), is an
RNA helicase of which expression is induced during differentiation,
cancer reversion, and apoptosis (Kang et al., 2002, 2004). The level of
MDA-5 mRNA remains low in normal tissues, however IFN-β induces
its expression in a number of normal and cancer cells (Kang et al.,
2004). NALP2 has been shown to modulate an inﬂammatory response
by inhibiting the NF-κB signaling pathway.NALP2mRNAwas detected
by RT-PCR to be expressed at low levels in HEK293T cells. Its
expression is however upregulated by NF-κB activators (Fontalba et
al., 2007). According to the UniGene proﬁle, NALP4 is expressed at low
levels in less than 10 tissues. NALP4, also known as NLRP4, has been
suggested to play a role in controlling inﬂammatory responses by
suppressing TNFα- and IL-1β-induced NF-κB activation in HEK293
cells (Fiorentino et al., 2002). Moreover, NALP4 has been shown toFig. 4. Tissue expression proﬁles for active and silent promoter fragments. EST proﬁles
from 45 tissues for genes corresponding to cloned promoters were obtained from the
UniGene database. For each gene, the number of tissues in which ESTs have been
observed was counted, and bins of these EST tissue numbers were plotted against the
fraction of each active and silent promoter. The corresponding genes of 68.8% of the
active promoters were expressed in more than 25 out of 45 tissues, while 50.0% of the
inactive promoters were expressed in less than 10 tissues.have a very low expression level in human embryos (Zhang et al.,
2008). TLR1, in conjunction with TLR2, has been shown to recognize
triacylated lipopeptides (Takeuchi et al., 2002; Alexopoulou et al.,
2002) and lead to activation of pro-inﬂammatory cytokine secretion
(Sandor et al., 2003). The mRNA levels for TLR1 remain low, as
determined previously using RT-PCR (Kurt-Jones et al., 2004; Farhat et
al., 2008), which is consistent with our ﬁndings. The low endogenous
mRNA levels of the IFIH1, NALP2, NALP4 and TLR1 genes might suggest
the presence of distal silencing elements acting on the respective
promoters, which were not present in the transfected plasmid
promoter constructs. The NALP4 has transcript variants with alterna-
tive TSSs, which may further contribute to the discrepancy between
elevated promoter activity and absence of the respective transcript
observed in our study. It should be emphasized that the cell array-
based assay for high-throughput promoter activity screening should
be treated as a pre-selection platform. Promoter candidates with
interesting activity patterns can be selected for further studies using,
for example, deletional analysis or transfection into non-adherent
cells, since these cells cannot be applied to reverse transfection on cell
arrays.
For a number of genes that are expressed at relatively high levels in
HEK293T cells, the corresponding promoters were inactive in the TCA
assay. Several explanations might account for this discrepancy. First,
due to the complexity of transcriptional initiation mechanisms and
the difﬁculty of TSS prediction, non-functional or alternative TSSs of
tissue-speciﬁc transcript variants might have been selected during
fragment design. Second, the presence of negative regulatory
elements might suppress the activity of some promoters to an
undetectable level or totally inactivate the promoter. On the other
hand, the positive elements required for initiation of transcription
may be located outside of the cloned fragment. Furthermore,
experimental noise in promoter activity measurements might lead
to an underestimation of activity and thus contribute to the observed
differences. Nevertheless, the analytic efﬁciency of the cell array due
to its high-throughput compensates for the relatively high false
negative rate.Fig. 5. The presence of core promoter sequence elements in cloned promoters. The
promoter sequence motifs TATA box and CpG islands were detected in the cloned
promoters. Among the active promoters, 43.8% and 37.5% contained the CpG islands
and TATA box, respectively. Among the silent promoters, 12.1% contained CpG islands
and 34.5% contained a TATA box.
54 X. Cheng et al. / Gene 450 (2010) 48–54The presence of promoter sequence motifs was compared with
promoter activity, and enrichment of CpG islands was found in active
promoters. However, no obvious enrichment of TATA boxes was
observed in active promoters. Promoter sequence features were also
compared with the tissue-speciﬁc expression of the corresponding
genes. Of the 32 genes that were expressed in less than 10 tissues, 17
(53.1%) promoters had a TATA box and only 3 (9.4%) had CpG islands.
In contrast, among the 9 genes expressed in more than 30 tissues, 3
(33.3%, DTNBP1, CARD8, and IFIH1) and 5 (55.6%, BIRC2, BIRC5, RIPK2,
PTK9L, and DTNBP1) promoters had a TATA box and CpG islands,
respectively. These observations conﬁrm the previous description by
Schug et al. (2005), reporting that TATA box-containing promoters are
commonly associated with tissue-speciﬁc genes, while CpG islands
are found in more ubiquitously expressed genes.
In summary, this studydemonstrates that the TCA technique, together
with gene expression and bioinformatics tools, represents a robust
technology for large-scale functional studies of regulatory sequences.
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